Poly(ethylene glycol)-avidin bioconjugates: Suitable candidates for tumor pretargeting

Journal of Controlled Release

Volumn 83, Issue 1, 2002, Pages 97-108

  Caliceti, Paolo ^a   Chinol, Marco ^b   Roldo, Marta ^a   Veronese, Francesco M ^a   Semenzato, Alessandra ^a   Salmaso, Stefano ^a   Paganelli, Giovanni ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Avidin; Bioconjugates; Poly(ethylene glycol); Pretargeting

Indexed keywords

AROMATIC AMINO ACID; BIOTIN; MACROGOL AVIDIN CONJUGATE; MACROGOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; CIRCULATION; CONTROLLED STUDY; DERIVATIZATION; DOSE TIME EFFECT RELATION; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG BINDING; DRUG CONJUGATION; DRUG TARGETING; IMMUNOGENICITY; KIDNEY; LIVER; MALE; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SOLID TUMOR;

ANIMALS; AVIDIN; DRUG DELIVERY SYSTEMS; MALE; MICE; MICE, INBRED BALB C; POLYETHYLENE GLYCOLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037130563     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00199-2     Document Type: Article

References (36)

1. Goodwin D.A., Meares C.F. Advances in pretargeting biotechnology. Biotechnol. Adv. 19:2001;435-450.
2. Paganelli G., Magnani P., Zito F., Villa E., Sudati F., Lopalco L., Rossetti C., Malcovati M., Chiolerio F., Seccamani E., Siccardi A.G., Fazio F. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 51:1991;5960-5966.
3. Chinol M., Grana C., Gennari R., Cremonesi M., Geraghty J.G., Paganelli G. Pretargeted radioimmunotherapy of cancer. Abrams P.G., Fritzberg A.R., Radioimmunotherapy of Cancer. 2000;169-193 Marcel Dekker, New York.
4. Paganelli G., Grana C., Chinol M., Cremonesi M., De Cicco C., De Braud F., Robertson C., Zurrida S., Casadio C., Zoboli S., Siccardi A.G., Veronesi U. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur. J. Nucl. Med. 26:1999;348-357.
5. 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results. Cancer Biother. Radiopharm. 16:2001;227-235.
6. Grana C., Chinol M., Robertson C., Mazzetta C., Bartolomei M., De Cicco C., Fiorenza M., Gatti M., Caliceti P., Paganelli G. Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study. Br. J. Cancer. 86:2002;207-212.
7. Paganelli G., Chinol M., Maggiolo M., Sidoli A., Corti A., Baroni S., Siccardi A.G. The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy. Eur J. Nucl. Med. 24:1997;350-351.
8. Grana C., Chinol M., Magnani P., Corti A., Sidoli A., Siccardi A.G., Paganelli G. In vivo tumor targeting based on the avidin-biotin system. Tumor Target. 2:1996;230-239.
9. Harris J.M., Zilpsky S., Poly(Ethylene Glycol): Chemistry and Biological Applications. 1997;American Chemical Society, Washington.
10. Delgado C., Francis G.E., Fisher D. The uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drugs Carrier Syst. 9:1992;249-304.
11. Kartre K. The conjugation of proteins with polyethylene glycol and other polymers. Adv. Drug Deliv. Rev. 10:1993;91-114.
12. Monfardini C., Veronese F.M. Stabilisation of substances in circulation. Bioconjug. Chem. 9:1998;418-450.
13. Caliceti P., Morpurgo M., Schiavon O., Monfardini C., Veronese F.M. Preservation of thrombolytic activity of urokinase modified with monomethoxypoly(ethylene glycol). J. Bioact. Comp. Pol. 9:1994;252-266.
14. Chinol M., Casalini P., Maggiolo M., Canevari S., Omodeo E.S., Caliceti P., Veronese F.M., Cremonesi M., Chiolerio E., Nardone E., Siccardi A.G., Paganelli G. Biochemical modifications of avidin improve pharmacokinetics, biodistribution and reduce immunogenicity. Br. J. Cancer. 79:1998;189-197.
15. Sims G.E.C., Snape T.J. A method for estimation of poly(ethylene glycol) in plasma protein fractions. Anal. Biochem. 107:1980;60-63.
16. Habeeb A.F.S.A. Determination of free amino groups in proteins by trinitrobenzensulfonic acid. Anal. Biochem. 14:1966;328-336.
17. Sartore L., Caliceti P., Schiavon O., Veronese F.M. Enzyme modification by MPEG with an amino acid or peptide as space arms. Appl. Biochem. Biotechnol. 27:1991;45-54.
18. Green N.M. A spectrophotrometric assay for avidin and biotin based on binding of dyes by avidin. Biochem. J. 94:1965;23-24.
19. Caliceti P., Schiavon O., Veronese F.M. Immunological properties of uricase conjugated to neutral soluble polymers. Bioconjug. Chem. 12:2001;515-522.
20. Yamaoka T., Tabata Y., Ikada Y. Distribution and tissue uptake of poly(ethylene glycol)with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83:1994;601-606.
21. Bowen S., Tare N., Inoue T., Yamasaki M., Okabe M., Horii I., Eliason J.F. Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein. Exp. Hematol. 27:1999;425-432.
22. 2 by amine-specific PEGylation with preserved bioactivity. Int. J. Pharm. 198:2000;83-95.
23. Green N.M., Melamed M.D. Optical rotary dispersion, circular dichroism and far-ultraviolet spectra of avidin and strepatvidin. Biochem. J. 100:1966;614-621.
24. Pugliese L., Coda A., Malcovati M., Bolognesi M. Three-dimensional structure of tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 Å resolution. J. Mol. Biol. 231:1993;698-710.
25. Giltin G., Bayer E.A., Wilchek M. Studies on the biotin-binding sites of avidin and streptavidin. Biochem. J. 269:1990;527-530.
26. Livnah O., Bayer E.A., Wilchek M., Sussman J.L. Three-dimensional structures of avidin and the avidin-biotin complex. Proc. Natl. Acad. Sci. 90:1993;5076-5080.
27. Eleison D., Hinton J., Hubbard S.J., Beynon R.J. Limited proteolysis of native proteins: the interaction between avidin and proteinase K. Protein Sci. 4:1995;1337-1345.
28. Paganelli G., Magnano P., Siccardi A.G., Fazio F. Clinical application of the avidin-biotin system for tumor targeting. Goldenberg D.M., Cancer Therapy With Radiolabeled Antibodies. 1995;239-254 CRC Press, New York.
29. Woolley D.W., Longsworth L.G. J. Biol. Chem. 142:1942;2885.
30. Conover C.D., Gilbert C.W., Shum K.L., Shorr R.L. The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Artif. Org. 21:1997;907-915.
31. Yabe Y., Nishikawa M., Tamada A., Takakura Y., Hashida M. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase. J. Pharmacol. Exp. Ther. 289:1999;1176-1184.
32. Schecter B., Silberman R., Arnon R., Wilchek M. Tissue distribution and streptavidin injected to mice: effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur. J. Biochem. 189:1990;327-331.
33. Rosebrough S.F. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin. Nucl. Med. Biol. 20:1993;663-668.
34. Hurwitz E., Klapper L.N., Wilchek M., Yarden Y., Sela M. Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti ErbB2 antibodies. Cancer Immunol. Immunother. 49:2000;226-234.
35. Sawa T., Wu J., Akaike T., Maeda H. Tumor-targeting chemotherapy by xanthine oxidase-polymer conjugate that generates oxygen-free radicals in tumor tissue. Cancer Res. 60:2000;666-671.
36. Delgado C., Pedley R.B., Harraez A., Boden R., Keep P.A., Chester K.A., Fisher D., Begent R.H.J., Francis G.E. Enhanced tumor specificity of an anti-carcinoembronic antigen Fab′ fragment by poly(ethylene glycol) (PEG) modification. Br. J. Cancer. 73:1996;175-186.